Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study

Janelidze, S., Collij, L. E., Mattsson-Carlgren, N., Antill, A., Laymon, C. M., Lott, I., Rosas, H. D., Minhas, D. S., Luo, W., Zaman, S., Mapstone, M., Head, E., Lai, F., Hartley, S. L., Ances, B. M., Krinsky-McHale, S. J., Lee, J. H., Ossenkoppele, R., Christian, B. T., … Hansson, O. (2025). Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study. The Lancet Neurology, 24(7), 591–600. https://doi.org/10.1016/s1474-4422(25)00158-9
Authors:
Shorena Janelidze
Lyduine E Collij
Niklas Mattsson-Carlgren
Alex Antill
Charles M Laymon
Ira Lott
H Diana Rosas
Davneet S Minhas
Weiquan Luo
Shahid Zaman
Mark Mapstone
Elizabeth Head
Florence Lai
Sigan L Hartley
Beau M Ances
Sharon J Krinsky-McHale
Joseph H Lee
Rik Ossenkoppele
Bradley T Christian
Benjamin L Handen
Oskar Hansson
Affiliated Authors:
Joseph H Lee
Subjects:
Publication Type:
Article
Unique ID:
10.1016/s1474-4422(25)00158-9
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: